Insider · CIK 0001578367

Fischer Meredith B

Reports to the SEC for 1 company · HAZELWOOD, MO

sec.gov

Transactions

Companies

Filings

CIK

0001578367

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-01-04	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−267 sh	$23.40	−$6,247.8	28,318
2018-01-03	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−467 sh	$23.51	−$11K	28,585
2018-01-02	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+1,037 sh	—	—	29,745
2018-01-02	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−693 sh	$23.52	−$16.3K	29,052
2017-08-30	Keenova Therapeutics plcP Purchase	Chief Public Affairs Officer	PPurchase	+1,280 sh	$39.63	+$50.7K	28,708
2017-07-01	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−494 sh	$44.81	−$22.1K	27,286
2017-03-01	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−149 sh	$51.55	−$7,680.95	27,418
2017-02-23	Keenova Therapeutics plcP Purchase	Chief Public Affairs Officer	PPurchase	+2,000 sh	$54.34	+$109K	27,567
2017-01-04	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−214 sh	$53.19	−$11.4K	25,443
2017-01-03	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+4,833 sh	—	—	25,657
2017-01-03	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	Chief Public Affairs Officer	AAward	+27.2K sh	—	—	27,151
2017-01-02	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+4,620 sh	—	—	22,493
2017-01-02	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−1,669 sh	$49.82	−$83.1K	20,824
2016-07-01	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−531 sh	$61.84	−$32.8K	17,612
2016-02-26	Keenova Therapeutics plcP Purchase	Chief Public Affairs Officer	PPurchase	+900 sh	$69.52	+$62.6K	17,643
2016-02-26	Keenova Therapeutics plcP Purchase	Chief Public Affairs Officer	PPurchase	+500 sh	$70.30	+$35.2K	18,143
2016-01-04	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+2,755 sh	—	—	16,743
2016-01-04	Keenova Therapeutics plcEmployee Share Options (Right to Buy)A Award	Chief Public Affairs Officer	AAward	+18K sh	—	—	18,003
2016-01-02	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−292 sh	$74.63	−$21.8K	13,988
2015-11-27	Keenova Therapeutics plcP Purchase	Chief Public Affairs Officer	PPurchase	+2,200 sh	$66.93	+$147K	14,280
2015-08-21	Keenova Therapeutics plcP Purchase	Chief Public Affairs Officer	PPurchase	+224 sh	$89.02	+$19.9K	12,080
2015-03-01	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−764 sh	$116.72	−$89.2K	11,856
2015-01-02	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+1,651 sh	—	—	12,752
2015-01-02	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−132 sh	$96.96	−$12.8K	12,620
2015-01-02	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Chief Public Affairs Officer	AAward	+11.2K sh	—	—	11,150
2014-03-01	Keenova Therapeutics plcF Tax Payment	Chief Public Affairs Officer	FTax Payment	−794 sh	$67.69	−$53.7K	11,101
2014-01-02	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+1,364 sh	—	—	11,895
2014-01-02	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Chief Public Affairs Officer	AAward	+8,237 sh	—	—	8,237
2013-07-01	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+3,182 sh	—	—	10,531
2013-07-01	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Chief Public Affairs Officer	AAward	+9,117 sh	—	—	9,117
2013-06-28	Keenova Therapeutics plcA Award	Chief Public Affairs Officer	AAward	+7,349 sh	—	—	7,349
2013-06-28	Keenova Therapeutics plcShare Options (Right to Buy)A Award	Chief Public Affairs Officer	AAward	+8,610 sh	—	—	8,610

Recent filings

Accepted (ET)
Jan 54
Fischer Meredith B0000950138-18-000039
SEC(opens sec.gov)
Jan 44
Fischer Meredith B0000950138-18-000026
SEC(opens sec.gov)
Sep 14
Fischer Meredith B0000950138-17-000616
SEC(opens sec.gov)
Jul 54
Mallinckrodt plc0000950138-17-000520
SEC(opens sec.gov)
Mar 34
Mallinckrodt plc0000950138-17-000271
SEC(opens sec.gov)
Feb 274
Mallinckrodt plc0000950138-17-000222
SEC(opens sec.gov)
Jan 64
Mallinckrodt plc0000950138-17-000035
SEC(opens sec.gov)
Jan 44
Mallinckrodt plc0000950138-17-000023
SEC(opens sec.gov)
Jul 64
Mallinckrodt plc0000950138-16-001183
SEC(opens sec.gov)
Mar 14
Mallinckrodt plc0001445064-16-000209
SEC(opens sec.gov)
Jan 54
Mallinckrodt plc0001445064-16-000188
SEC(opens sec.gov)
Dec 14
Mallinckrodt plc0001445064-15-000142
SEC(opens sec.gov)

Companies

Keenova Therapeutics plcChief Public Affairs Officer

Address

C/O MALLINCKRODT PLC 675 JAMES S. MCDONNELL BLVD.

HAZELWOOD, MO, 63042